Reckitt Benckiser, which also makes Nurofen, Strepsils and Gaviscon, and Cillit Bang cleaning products, estimated on Thursday that like-for-like revenue in the second quarter of the year would decrease by 2 per cent because of the attack.
“The attack did disrupt the company’s ability to manufacture and distribute products to customers in multiple markets,” Reckitt Benckiser said. “Consequently, we were unable to ship and invoice some orders to customers prior to the close of the quarter.”
RB added that some of its factories were still not operating normally, “but plans are in place to return to full operation”.
It also said that, to a lesser extent, the implementation of a new tax in India had resulted in reduced orders from some customers throughout June.
The company expects some of the revenue lost during the second quarter to be recovered in the third quarter of 2017.
“However, the continued production difficulties in some factories mean that we also expect to lose some further revenue permanently.”
Danish shipping company Maersk and British advertising company WPP were also hit by June’s attack, which originated in Ukraine. A hospital in the US and pharmaceutical company Merck also fell victim. Cadbury-owner Mondelez was forced to temporarily halt production in one of its factories in Australia.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies